Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum therapy revisited: animal models of infection and development of passive antibody therapy.

Literature DB >> 7985997

Serum therapy revisited: animal models of infection and development of passive antibody therapy.

A Casadevall¹, M D Scharff.

Abstract

Entities: Disease

Mesh：

Year: 1994 PMID： 7985997 PMCID： PMC284624 DOI： 10.1128/AAC.38.8.1695

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

10 in total

1. Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors: G Köhler; C Milstein
Journal: Nature Date: 1975-08-07 Impact factor: 49.962

2. Serological relationships among meningococci.

Authors: S E BRANHAM
Journal: Bacteriol Rev Date: 1953-09

3. THE MENINGOCOCCUS (NEISSERIA INTRACELLULARIS).

Authors: S E Branham
Journal: Bacteriol Rev Date: 1940-06

4. IMMUNIZATION OF HUMAN SUBJECTS WITH THE SPECIFIC CARBOHYDRATES OF TYPE III AND THE RELATED TYPE VIII PNEUMOCOCCUS.

Authors: M Finland; J M Ruegsegger
Journal: J Clin Invest Date: 1935-11 Impact factor: 14.808

5. EXPERIMENTAL MENINGOCOCCAL INFECTION IN MICE.

Authors: C P Miller
Journal: Science Date: 1933-10-13 Impact factor: 47.728

6. TYPE SPECIFIC ANTIPNEUMOCOCCUS RABBIT SERUM.

Authors: F L Horsfall; K Goodner; C M Macleod
Journal: Science Date: 1936-12-25 Impact factor: 47.728

7. A STATISTICAL REVIEW OF 525 CASES OF LOBAR PNEUMONIA.

Authors: A H Maccordick
Journal: Can Med Assoc J Date: 1931-12 Impact factor: 8.262

Review 8. In vitro antibodies: strategies for production and application.

Authors: S L Morrison
Journal: Annu Rev Immunol Date: 1992 Impact factor: 28.527

9. Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.

Authors: A F LoBuglio; R H Wheeler; J Trang; A Haynes; K Rogers; E B Harvey; L Sun; J Ghrayeb; M B Khazaeli
Journal: Proc Natl Acad Sci U S A Date: 1989-06 Impact factor: 11.205

10. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.

Authors: R W Schroff; K A Foon; S M Beatty; R K Oldham; A C Morgan
Journal: Cancer Res Date: 1985-02 Impact factor: 12.701

10 in total

79 in total

Review 1. Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle.

Authors: Arturo Casadevall
Journal: Infect Immun Date: 2003-08 Impact factor: 3.441

Review 2. Back to the future: antibody-based strategies for the treatment of infectious diseases.

Authors: H Barbaros Oral; Cüneyt Ozakin; Cezmi A Akdiş
Journal: Mol Biotechnol Date: 2002-07 Impact factor: 2.695

3. Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice.

Authors: Haijun Tian; Avi Groner; Marianne Boes; Liise-anne Pirofski
Journal: Infect Immun Date: 2007-01-12 Impact factor: 3.441

4. Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsule.

Authors: T R Kozel; B C deJong; M M Grinsell; R S MacGill; K K Wall
Journal: Infect Immun Date: 1998-04 Impact factor: 3.441